Lamivudine Tablet, Film Coated
Product Images NDC 60505-3250

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60505-3250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

FDA Label Image

Container-label.jpg (Container Label)

Container-label.jpg (Container Label)
This is a medication called Eact firkcodiod Bt available in tablet form. The NDC code for this medication is 60505-3250-6. Each tablet contains 100 mg of lamivudine, and the tablets are used to treat hepatitis B virus infection. It is recommended to store the medication at a temperature of 20°C to 25°C (59°F to 86°F) and protect it from moisture. The pharmacists are advised to dispense the enclosed patient information leaflet along with the medication to each patient. The manufacturer of the medication is Apotex Corp., located in Weston, Florida.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.